Enhance your practice with CME and tools that focus on the management of neurological conditions.
The Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN
Navigating Stem Cell Therapy Conversations in MS
Jaime Imitola, MD
Measuring Migraine: The Potential of CGRP
Shradha Kakde, MBBS
Improving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
Jay Max Findlay
Advancing Cognitive Screening and Monitoring in MS
Elizabeth S. Gromisch, PhD
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
Rethinking Vestibular Migraine in Clinical Practice
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Tracy Hicks, DNP, MBA
Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
Melissa Moody, MD
Tardive Dyskinesia, Decoded: From Subtle Signs to Personalized VMAT2 Therapy
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
The Recovery Trajectory of Subarachnoid Hemorrhage
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
How Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
Cognitive Screening in MS: Practical Strategies and Modern Approaches
Movements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Not All VMAT2s Are the Same: Understanding the PK/PD Differences
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.